ClinicalTrials.Veeva

Menu

The Application of Symptoms Management Program Based on the Patient Reported Outcome After Esophagectomy

Chinese Academy of Medical Sciences & Peking Union Medical College logo

Chinese Academy of Medical Sciences & Peking Union Medical College

Status

Not yet enrolling

Conditions

Esophageal Cancer

Treatments

Device: Smart Symptom Management Program

Study type

Interventional

Funder types

Other

Identifiers

NCT07187154
NCC3765

Details and patient eligibility

About

  1. Research methods Constructed the "Manual for Graded Management of Postoperative Symptoms of Esophageal Cancer" and developed continuous care Procedures.
  2. Randomised controlled studies were conducted to verify the effects of the procedure.

Enrollment

252 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • The patient is aware and able to communicate in Mandarin;
  • There are smartphones;
  • Proficient in using WeChat mini programs.
  • Patients who were scheduled for esophageal cancer resection in participating centers were eligible for inclusion.

Exclusion criteria

  • Have cognitive impairment or psychiatric illness;
  • Refusal to participate

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

252 participants in 2 patient groups

Group 1:Smart Symptom Management Program
Experimental group
Description:
During the first six months after surgery, patients in the experimental group will use a WeChat mini-program to proactively self-report their symptoms regularly using the Chinese version of the MD Anderson Symptom Inventory for Esophageal Cancer (MDASI-EC). Based on the reported scores and the pre-defined algorithms in the "Post-Esophagectomy Symptom Grading Management Manual", the system will automatically provide personalized self-management guidance for low-grade symptoms. For more severe symptoms, the system will generate alerts to prompt dedicated study nurses to initiate proactive telephone follow-up and provide tailored health coaching.
Treatment:
Device: Smart Symptom Management Program
Group 2:Routine Care
No Intervention group
Description:
Patients in the control group will receive standard post-discharge care as per hospital protocol, which includes routine discharge education and instructions to contact the hospital if problems arise. They will not use the WeChat mini-program and will not receive proactive symptom monitoring or coaching calls.

Trial contacts and locations

1

Loading...

Central trial contact

YUAN YU

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems